Jerry L. Halpern, DDS
Oral and Maxillofacial Surgery; Craniofacial and Oral Implants; Dental Oncology
New Patient Appointments
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.
DDS, Howard University College of Dentistry
General Practice - New York Presbyterian Hospital; Oral and Maxillofacial Surgery - New York Presbyterian Hospital
Oral and Maxillofacial Surgery; Dental General Anesthesia
I am a board-certified oral and maxillofacial surgeon with more than 35 years of experience in the surgical management and treatment of the upper and lower jaws and the nearby structures of the face. I have been at Memorial Sloan Kettering for more than 23 years, both operating and teaching fellows in the maxillofacial prosthetic and dental oncology programs and caring for the special oral and dental needs of cancer patients. I treat benign lesions of the jaws, traumatic injuries, and oral infections, and perform dental and reconstructive jaw surgery.
My special area of expertise is reconstruction in which implants are integrated into bone, especially in patients with defects of the face and jaws related to cancer surgery, traumatic injury, or congenital growth abnormalities. I am also board certified in dental general anesthesia. I work as part of a collaborative team of head and neck surgeons, plastic surgeons, and maxillofacial prosthodontists in planning and placing implants both inside and outside the mouth following cancer surgery. I also provide bone graft reconstruction, if needed, to rebuild defects to support future prostheses.
My research interests currently involve investigating the role that agents called bisphosphonates, which are used in the treatment of certain cancers, play in osteonecrosis of the jaw. In addition to my clinical and teaching activities I am a forensic odontologist (a specialist who uses teeth and other nearby structures as a means of identification) and currently a member of M.E.S.O.R.T. (medical examiner special operations response team) for the Chief Medical Examiner for the City of New York. I was actively involved in the identification process for the victims of the 9/11 World Trade Center disaster and the crash of American Airlines Flight 587 the same year. I have been honored by New York City, New York State, and the US House of Representatives for my forensic work. In 2005 I was inducted into the American Academy of Forensic Sciences. I am currently the Chairman of the New York section of the American College of Dentists.
I am involved in organized dentistry on both a state and national level, and I am currently the Chairman of the New York Academy of Dentistry Humanitarian Outreach Committee. For the past eight years, in conjunction with three local dental schools and hospital oral and maxillofacial residents, general practice residents, and dentists, we have traveled to the Dominican Republic to treat underserved children and medically compromised HIV patients. This work is now part of the World of Smiles Foundation, of which I am President. I am the immediate past president of the New York State Society of Oral and Maxillofacial Surgeons and I am also involved with the American Association of Oral and Maxillofacial Surgeons as Chairman of the Dental Anesthesia Assistants National Certification committee. I have presented lectures at the annual meeting of the American Association of Oral and Maxillofacial Surgeons on emergent anesthesia care and implant surgical placement techniques.
In 2010, I received the AAOMS Presidential Achievement Award in Oral and Maxillofacial Surgery. This award is given by the Board of Trustees to recognize a member or fellow for important long-standing contributions of benefit to the specialty of oral and maxillofacial surgery through clinical, academic, research, or public service activities. This is one of the highest awards given by the specialty of Oral and Maxillofacial Surgery. In 2018, I was awarded the Humanitarian Award at the 100th AAOMS National Scientific Meeting, for my ongoing outreach work in the Dominican Republic.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Visit PubMed for a full listing of Dr. Halpern’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jerry L. Halpern discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.